Treprostinil Inhalation Powder ( DrugBank: Treprostinil )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	2

86. 肺動脈性肺高血圧症

---

臨床試験数 : 1,205 /  薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03950739 (ClinicalTrials.gov)	September 17, 2019	9/5/2019	Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso	An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso	Pulmonary Arterial Hypertension	Drug: Treprostinil Inhalation Powder	United Therapeutics	NULL	Active, not recruiting	18 Years	N/A	All	51	Phase 1	United States
2	NCT03464864 (ClinicalTrials.gov)	March 9, 2018	1/3/2018	Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder in Healthy Normal Volunteers	A Phase 1, Single-center, Open-label, Dose-Rising Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of Treprostinil Inhalation Powder (TrIP) in Healthy Normal Volunteers	Pulmonary Arterial Hypertension	Drug: Treprostinil Inhalation Powder	Mannkind Corporation	NULL	Completed	18 Years	55 Years	All	36	Phase 1	United States